Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.87 USD
0.29%
Market Closed
Updated:
May 16, 2024
Amneal Pharmaceuticals Inc
Other Operating Expenses
|
Amneal Pharmaceuticals Inc
Other Operating Expenses Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Other Operating Expenses
$15.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Operating Expenses
$1.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Operating Expenses
$2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
57%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Operating Expenses
$1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Amneal Pharmaceuticals Inc's Other Operating Expenses?
Other Operating Expenses
15.6m
USD
15.6m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Other Operating Expenses amounts to 15.6m USD.
What is Amneal Pharmaceuticals Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
384%
384%
Over the last year, the Other Operating Expenses growth was 384%.
You don't have any saved screeners yet
